RecallRadar

FDA Drug recall D-0644-2025

chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 384…

On 2025-09-17 the FDA classified a Class II recall of chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 384… by Avkare, citing presence of a foreign substance.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0644-2025
ClassificationClass II
Statusongoing
Initiated2025-08-25
Published2025-09-17
Last updated2026-09-13 11:52 UTC
CompanyAvkare
DistributionUS

Product

chloroproMAZINE Hydrochloride Tablets, USP, 100 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-165-15

Reason

Presence of a foreign substance.

Identifiers

ndc50268-162-11
ndc50268-162-15
ndc50268-163-11
ndc50268-163-15
ndc50268-164-11
ndc50268-164-15
ndc50268-165-11
ndc50268-165-15
ndc50268-166-11
ndc50268-166-12
code_infoLot # 47089, Exp 12/31/25; 47604, Exp 03/31/26

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0644-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.